Prudential Financial’s Terns Pharmaceuticals TERN Stock Holding History

Prudential Financial’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-96,740	Closed	-$5.1M	–	2587
2026 Q1	$5.1M	Buy	96,740 +62,440	+182%	+$2.56M	0.01%	910
2025 Q4	$1.39M	Sell	34,300 -34,820	-50%	-$805K	﹤0.01%	1482
2025 Q3	$519K	Buy	+69,120	New	+$441K	﹤0.01%	1936

Other funds holding TERN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Prudential Financial's TERN Position: Q2 2026 in Review

Prudential Financial sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 96,740 shares — an estimated $5.1M sold.

Prudential Financial first reported a position in TERN in Q3 2025 and held it in 3 quarters. The position peaked at $5.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Prudential Financial reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Prudential Financial sold 96,740 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.1M.
Prudential Financial first reported a position in Terns Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Prudential Financial's Terns Pharmaceuticals position peaked at $5.1M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.